Vaccination against feline leukaemia using a new feline herpesvirus type 1 vector

Vaccine

Volumn 14, Issue 16, 1996, Pages 1511-1516

  Willemse, Marja J ^a,b   Van Schooneveld, Saskia H B ^d   Chalmers, W Stuart K ^c   Sondermeijer, Paul J A ^a,b  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b NV ORGANON   (Netherlands)

^c Intervet UK   (United Kingdom)

^d NONE

Author keywords

FeLV; FHV 1; Herpesvirus; Recombinant; Vaccine

Indexed keywords

FELINE LEUKEMIA VIRUS VACCINE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; FELINE LEUKEMIA VIRUS; HERPES SIMPLEX VIRUS 1; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

ADMINISTRATION, INTRANASAL; ANIMALS; CATS; GENE EXPRESSION REGULATION, VIRAL; GENES, ENV; GENETIC VECTORS; HERPESVIRIDAE; LEUKEMIA VIRUS, FELINE; LEUKEMIA, FELINE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 17144447763     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00108-9     Document Type: Article

References (34)

1. 1 Lutz, H. Feline retroviruses: a brief review. Vet. Microbiol. 1990, 23, 131-146
2. 2 Cotter, S.M. Feline leukemia virus: pathophysiology, prevention, and treatment. Cancer Invest. 1992, 10, 173-181
3. 3 Pedersen, N.C., Johnson, L., Birch, D. and Theilen, G.H. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective. Vet. Immun. Immunopath. 1986, 11, 123-148
4. 4 Marciani, D.J., Kensit, C.R., Beltz, G.A., Hung, C., Cronier, J. and Aubert, A. Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine 1991, 9, 89-96
5. 5 Pedersen, N.C., Theilen, G.H. and Werner, L.L. Safety and efficacy studies of live-and killed-feline leukemia virus vaccines. Am. J. Vet. Res. 1979, 40, 1120-1126
6. 6 Lewis, M.G., Mathes, L.E. and Olsen, R.G. Protection against feline leukemia by vaccination with a subunit vaccine. Infect. Immun. 1981, 34, 888-894
7. 7 Osterhaus, A., Weijer, K., UytdeHaag, F., Jarrett, O., Sundquist, B. and Morein, B. Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOMS. J. Immun. 1985, 135, 591-596
8. 8 Haffer, K.N., Koertje, W.D., Derr, J.T. and Beckenhauer, W.H. Evaluation of immunosuppressive effect and efficacy of an improved-potency feline leukaemia vaccine. Vaccine 1990, 8, 12-16
9. 9 Hoover, E.A., Perigo, N.A., Quackenbush, S.L. et al. Protection against feline leukemia virus infection by use of an inactivated virus vaccine. J. Am. Vet. Med. Assoc. 1991, 199, 1392-1401
10. 10 York, S.M. and York, C.J. Development of a whole killed feline leukemia virus vaccine. J. Am. Vet. Med. Assoc. 1991, 199, 1419-1427
11. 11 Pedersen, N.C. Immunogenicity and efficacy of a commercial feline leukemia vaccine. J. Vet. Intern. Med. 1993, 7, 34-39
12. 12 Pedersen, N.C. and Johnson, L. Evaluation of a commercial feline leukemia virus vaccine for immunogenicity and efficacy. Feline Pract. 1985, 15, 7-20
13. 13 Osterhaus, A., Weijer, K. and UytdeHaag, F. Comparison of aerological responses in cats vaccinated with two different FeLV vaccine preparations. Vet. Rec. 1987, 121, 260-271
14. 14 Legendre, A.M., Mitchener, K.L. and Potgieter, L.N. Efficacy of a feline leukemia virus vaccine in a natural exposure challenge. J. Vet. Intern. Med. 1990, 4, 92-98
15. 15 Pollack, R.V.H. and Scarlett, J.M. Randomized blind trial of a commercial FeLV vaccine. J. Am. Vet. Med. Assoc. 1990, 196, 611-616
16. 16 Legendre, A.M., Hawks, D.M., Sebring, R. et al. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure. J. Am. Vet. Med. Assoc. 1991, 199, 1456-1462
17. 17 Jarrett, O. and Ganière, J.P. Comparative studies of the efficacy of a recombinant feline leukemia virus vaccine. Vet. Rec. 1996, 138, 7-11
18. 18 Povey, R.C. A review of feline viral rhinotracheitis (feline herpesvirus 1 infection). Comp. Immun. Microbiol. Infect. Dis. 1979, 2, 373-387
19. 19 Gaskell, R.M. Vaccination of the young kitten. J. Small An. Prac. 1989, 30, 618-624
20. 20 Cole, G.E., Stacy-Phipps, S. and Nunberg, J.H. Recombinant feline herpesviruses expressing feline leukaemia virus envelope and gag proteins. J. Virol. 1990, 64, 4930-4938
21. 21 Willemse, M.L., Chalmers, W.S.K., Cronenberg, A.M., Pfundt, R., Strijdveen, I.G.L. and Sondermeijer, P.J.A. The gene down-stream of the gC homologue in feline herpesvirus type 1 is involved in the expression of virulence. J. Gen. Virol. 1994, 75, 3107-3116
22. 22 Wardley, R.C., Berlinski, P.J., Thomsen, D.R., Meyer, A.L. and Post, L.E. The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus. J. Gen. Virol. 1992, 73, 1811-1818
23. 23 Sondermeijer, P.J.A., Claessens, J.A.J., Jenniskens, P.E. et al. Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine 1993, 11, 349-358
24. 24 Stewart, M.A., Warnock, M., Wheeler, A. et al. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J. Virol. 1986, 58, 825-834
25. 25 Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbour Laboratory, Cold Spring Harbour, NY, USA, 1989
26. 26 Jarrett, O., Golder, M.C. and Stewart, M.F. Detection of transient and persistent feline leukaemia virus infections. Vet. Rec. 1982, 110, 225-228
27. 27 Madewell, B.R. and Jarrett, O. Recovery of feline leukaemia virus from non-viraemic cats. Vet. Rec. 1983, 112, 339-342
28. 28 Russel, P.H. and Jarrett, O. The occurrence of feline leukaemia virus neutralizing antibodies in cats. Int. J. Cancer 1978, 22, 351-357
29. 29 Spyropoulos, D.D., Roberts, B.E., Panicali, D.L. and Cohen, L.K. Delineation of the viral products of recombinations in vaccinia virus-infected cells. J. Virol. 1988, 62, 1046-1054
30. 30 Hoover, E.A., Olsen, R.G., Hardy, W.D., Schaller, J.P. and Mathes, L.E. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J. natl Cancer Inst. 1976, 57, 365-369
31. 31 Gilbert, J.H., Pederson, N.C. and Nunberg, J.H. Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animals. Virus Res. 1987, 7, 49-67
32. 32 Tartaglia, J., Jarrett, O., Neil, J.C., Desmettre, P. and Paoletti, E. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant ALVAC-FL. J. Virol. 1993, 67, 2370-2375
33. 33 Haffar, O., Garrigues, J., Travis, B., Moran, P., Zarling, J. and Hu, S.-L. Human deficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia expression system. J. Virol. 1990, 64, 2653-2659
34. 34 Pacitti, A.M. and Jarrett, O. Duration of the latent state in feline leukaemia virus infections. Vet. Rec. 1985, 117, 472-474